Live News Categoriesequity

Eisai Co., Ltd. (4523.T) News

Follow Eisai Co., Ltd. (4523.T) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 4523.T Asset equity Sector Markets 90 days 1 Last 4,868 Updated Oct 15, 2026, 12:14 PM UTC Open live news feed

L Eisai announces Phase 3 Lenvima combination trial analyses in advanced kidney cancer at ESMO 2026 Eisai will present final Phase 3 LITESPARK-011 results for advanced kidney cancer at ESMO in Madrid on October 25, 2026. The study supported recent FDA clearance of Welireg with Lenvima for adults with advanced clear-cel REGULATION | Oct 15, 2026, 12:14 PM UTC